Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes-Reference-Cited by-同舟云学术

Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes

Published:2021-04-30 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Kaytaz Tekyol Kübra,Gurleyik Gunay,Aktaş Ayşegül,Aker Fugen,Tanrikulu Eda,Tekyol Davut

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference28 articles.

1. Molecular portraits of human breast tumours;Perou CM;Nature,2000

2. Neoadjuvant chemotherapy for operable breast cancer;Mieog JS;Br J Surg,2007

3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar P;Lancet,2014

4. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy;Symmans WF;J Clin Oncol,2007

5. Biomarkers predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer;Li XB;Am J Clin Pathol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil to lymphocyte ratio does not behave as a good predictor of pathological complete response in breast cancer: A retrospective analysis in the neoadjuvant setting;Advances in Cancer Biology - Metastasis;2023-12

2. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis;BMJ Open;2023-11

3. Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part II. Hematological Markers of Inflammation;Annals of the Russian academy of medical sciences;2023-02-04

4. The Impact of Tumor Infiltrating Lymphocytes Densities and Ki67 Index on Residual Breast Cancer Burden following Neoadjuvant Chemotherapy;International Journal of Breast Cancer;2022-09-12

5. Inflammatory Related Reactions in Humans and in Canine Breast Cancers, A Spontaneous Animal Model of Disease;Frontiers in Pharmacology;2022-02-11